Vaccines, blood, antisera, toxins and cultures in   Luxembourg

Exports In 2022, Luxembourg exported $35.7M in Vaccines, blood, antisera, toxins and cultures, making it the 55th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 106th most exported product in Luxembourg. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Luxembourg are: Oman ($14.2M), Czechia ($7.34M), Belgium ($4.52M), United States ($2.96M), and Germany ($1.09M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Luxembourg between 2021 and 2022 were Oman ($8.51M), United States ($2.96M), and Cape Verde ($1.04M).

Imports In 2022, Luxembourg imported $112M in Vaccines, blood, antisera, toxins and cultures, becoming the 96th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 50th most imported product in Luxembourg. Luxembourg imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($49M), Belgium ($39.8M), Germany ($8.47M), Austria ($4.73M), and France ($3.82M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Luxembourg between 2021 and 2022 were Austria ($2.26M), Poland ($652k), and Sweden ($567k).